Gabriel SE . The epidemiology of gender-discrepant illness . Lupus1999; 8: 339–345 .
2.
Roger VL , Jacobsen SJ , Weston SA , Gabriel SE . Sex differences in the epidemiology and outcomes of heart disease: population-based trends . Lupus1999; 8: 346–350 .
3.
Leibson C.Loss of the female advantage with cardiovascular disease For women with diabetes . Lupus1999; 8: 351–355 .
Lockshin RA . Gender differences: the perspective from biology . Lupus1999; 8: 361–364 .
6.
Ostrer H . Sex-based differences in gene transmission and gene expression . Lupus1999; 8: 365–369 .
7.
Nelson JL . Microchimerism and autoimmune disease . Lupus1999; 8: 370–374 .
8.
Nikezic-Ardolic M , Lin L , Milcevic M , Zakeri Z . Gender differences in cellular response . Lupus1999; 8: 375–379 .
9.
Spitzer JA . Gender differences in some host defense mechanisms . Lupus1999; 8: 380–383 .
10.
Huber SA , Kupperman J , Newell MK . Estradiol prevents and testosterone promotes Fas-dependent apoptosis in CD4+ Th2 cells by altering Bcl 2 expression . Lupus1999; 8: 384–387 .
11.
Turner RT . Mechanical signaling in the development of postmenopausal osteoporosis . Lupus1999; 8: 388–392 .
12.
Khosla S , Melton LJ III , Riggs BL . Osteoporosis: gender differences and similarities . Lupus1999; 8: 393–396 .
13.
Fitzpatrick LA , Ruan M , Shogren K et al. Gender-related differences in vascular smooth muscle cell proliferation: implications for prevention of atherosclerosis . Lupus1999; 8: 397–401 .
14.
Dietz NM . Gender and nitric oxide-mediated vasodilation in humans . Lupus1999; 8: 402–408 .
15.
Miller VM . Gender and vascular reactivity . Lupus1999; 8: 409–415 .